Radrizzani M, Accornero P, Delia D, Kurrle R, Colombo M P
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milano, Italy.
FEBS Lett. 1997 Jul 7;411(1):87-92. doi: 10.1016/s0014-5793(97)00672-8.
HIV-gp120 sensitizes Th1 clones from seronegative donors to apoptosis, which occurs through two distinct events: expression of CD95L followed by its interaction with CD95 to trigger cell death. gp120-apoptosis of the Th1 clone 103 was inhibited by Cyclosporin A, the PTK inhibitors Genistein and PNU152518, as well as the anti-oxidants Ascorbic Acid and Glutathione. Cyclosporin A interfered with CD95L expression, Ascorbic Acid and Glutathione inhibited cell death triggered by CD95/CD95L interaction; Genistein and PNU152518 acted on both steps. The occurrence of oxidative stress during CD95-dependent apoptosis was supported by the direct evidence of ROI production.